Thromb Haemost 1978; 39(03): 592-599
DOI: 10.1055/s-0038-1646732
Original Article
Schattauer GmbH Stuttgart

The Influence of Residual Factor VII on the Sensitivity of Brain Thromboplastin

Neville W Spurling
The Department of Pathology, Medical Division, Allen and Hanburys Research Limited, Ware, Hertfordshire, U.K.
,
Janet Savory
The Department of Pathology, Medical Division, Allen and Hanburys Research Limited, Ware, Hertfordshire, U.K.
› Author Affiliations
Further Information

Publication History

Received 26 August 1977

Accepted 24 November 1977

Publication Date:
26 July 2018 (online)

Summary

One-stage prothrombin times of normal and of factor VII-deficient beagle plasma were determined with two types of beagle brain thromboplastin, one prepared from normal beagles and the other from factor VII-deficient beagles. There was little difference between the reagents in the prothrombin times obtained for normal plasma. However, when factor VII-deficient plasma was tested, reagent prepared from factor VII-deficient beagles gave considerably longer prothrombin times than were obtained with the normal reagent and the difference increased with increasing reagent concentration to a maximum at 140 mg/ml.

Prothrombin times of a series of mixtures of normal and factor VII-deficient plasma indicated that the presence of only 1/90 part of normal plasma was necessary to compensate for the difference between the two reagents. Determination of the iron content of the reagent suggested that the microcirculation of an average brain contained some 1.8 g of whole blood.

The finding that brain thromboplastin prepared from factor VII-deficient beagles is more sensitive to a deficiency of factor VII in plasma, presumably a result of the smaller quantity of factor VII present in the reagent, is compatible with the known kinetics of extrinsic coagulation.

 
  • References

  • Biggs R, Macfarlane RG. 1962. Human Blood Coagulation and its Disorders. third. edition Blackwell Scientific Publications; Oxford:
  • 1 Bjørklid E, Storm E, Osterud B, Prydz H. 1975; The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with factors VII and X. Scandinavian Journal of Haematology 14: 65
  • 2 Bose AN. 1945; On the mode of action of dicoumarin : part I. Annals of Biochemistry and Experimental Medicine 5: 105
  • 3 Denson KWE. 1964; Tissue extracts and their sensitivity to factor VII and factor X. Thrombosis et Diathesis Haemorrhagica 11: 146
  • 4 Denson KWE. 1976. Appendices. In: Biggs R. (ed.) Human Blood Coagulation, Haemostasis and Thrombosis. second. edition Blackwell Scientific Publications; Oxford: 655
  • 5 Hall DE. 1970; Sensitivity of different thromboplastin reagents to factor VII deficiency in the blood of beagle dogs. Laboratory Animals 4: 55
  • 6 Hawkey CM. 1975. Comparative Mammalian Haematology; Cellular Components and Blood Coagulation of Captive Wild Animals. Heinemann; London:
  • 7 Hawkey C, Stafford JL. 1961; Influence of serum factors on the species specificity of tissue thromboplastin. Nature 191: 920
  • 8 Hemker HC, Lindhout MJ, Reekers PPM. 1974; Demonstration of three proteins induced by vitamin K absence (PIVKAs)s. Thrombosis et Diathesis Haemorrhagica Suppl 59: 45
  • 9 Hemker HC, Siepel T, Altman R, Loeliger EA. 1967; Kinetic aspects of the interaction of blood-clotting enzymes. II. The relation between clotting time and plasma concentration in prothrombin-time estimations. Thrombosis et Diathesis Haemorrhagica 17: 349
  • 10 Mann FD, Hurn MM. 1952; Species specificity of thromboplastin: role of the cothromboplastin reaction. Proceedings of the Society for Experimental Biology and Medicine 79: 19
  • 11 Monro FL, Lupton AM. 1947; The influence of dicumarol treatment of rabbits, rats and dogs on the thromboplastic activity of their brain suspensions. Archives of Biochemistry 15: 245
  • 12 Østerud B, Berre Å, Otnaess AB, BjØrklid E, Prydz H. 1972; Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry 11: 2853
  • 13 Poller L, Thomson JM, Sear CHJ, Thomas W. 1971; Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma. Journal of Clinical Pathology 24: 626
  • 14 Radcliffe R, Nemerson Y. 1976; Mechanism of activation of bovine factor VII. Products of cleavage by factor X. Journal of Biochemistry 251: 4791
  • 15 Spurling NW. 1973 Canine factor-VII deficiency. In: IVth International Congress on Thrombosis and Haemostasis Vienna, 19–22 June 1973 Abstract Volume 439
  • 16 Spurling NW, Burton LK, Peacock R, Pilling T. 1972; Hereditary factor VII-deficiency in the beagle. British Journal of Haematology 23: 59
  • 17 Spurling NW, Burton LK, Pilling T. 1974; a Canine factor VII-deficiency: experience with a modified thrombotest method in distinguishing between the genotypes. Research in Veterinary Science 16: 228
  • 18 Spurling NW, Peacock R, Pilling T. 1974; b The clinical aspects of canine factor-VII deficiency including some case histories. Journal of Small Animal Practice 15: 229
  • 19 Stefanini M, Blanchaer MC. 1947; Action of 3,3’methylenebis (4-hydroxycoumarin) (Dicumarol) on thromboplastic activity of rabbit brain. Proceedings of the Society for Experimental Biology and Medicine 64: 47